Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
IMCR
#4436
Immunocore Holdings plc - American Depositary Shares
0.2
9
USD
-99.00%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-99.00%
Monthly Change
-98.97%
6 month change
-99.26%
Year Change
-99.14%
Previous Close
28.9
7
Open
0.2
9
Low
0.2
9
High
0.2
9
Volume
29
Markets
US Stock Market
Healthcare
IMCR
Open full chart
Full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
Current
Key stats
Total common shares outstanding
31.78 M
43.86 M
48.09 M
49.82 M
50.07 M
50.7 M
50.87 M
Valuation ratios
Enterprise value
—
1.5 B
2.67 B
3.17 B
1.41 B
1.69 B
1.39 B
Price to earnings ratio
—
—
—
-63.4
-28.92
-48.89
-50.89
Price to sales ratio
—
—
—
14.04
4.75
4.37
3.52
Price to cash flow ratio
—
—
—
1 191.29
56.59
-163.13
-59.25
Price to book ratio
—
—
—
9.5
4.09
4.59
0.93
Enterprise value to EBITDA ratio
—
—
—
-57.15
-21.31
-39.88
-44.72
Profitability ratios
Return on assets %
—
—
—
-0.09
-0.05
-0.03
0.01
Return on equity %
—
—
—
-0.15
-0.14
-0.09
0.03
Return on invested capital %
—
—
—
-126.09
-131.84
-126.65
10.73
Gross margin %
—
—
—
99.58
99.12
98.73
99.59
Operating margin %
—
—
—
-23.91
-22.71
-11.34
6.82
EBITDA margin %
—
—
—
-22.27
-21.36
-10.56
7.71
Net margin %
—
—
—
-22.17
-16.47
-8.88
12.16
Liquidity ratios
Quick ratio
—
—
—
3.77
4.36
4.01
4.15
Current ratio
—
—
—
3.8
4.38
4.04
4.18
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
—
—
—
0.42
0.39
0.37
0.1
Solvency ratios
Debt to assets ratio
—
—
—
0.08
0.39
0.37
0.37
Debt to equity ratio
—
—
—
0.13
1.08
1.03
1
Long term debt to total assets ratio
—
—
—
0.17
0.39
0.37
0.37
Long term debt to total equity ratio
—
—
—
0.27
1.08
1.03
1
Per share metrics
Operating cash flow per share
—
—
—
0.06
0.52
-0.21
-0.48
EBIT per share
—
—
—
-1.22
-1.41
-0.9
-0.69
EBITDA per share
—
—
—
-1.14
-1.33
-0.84
-0.63
Total debt per share
—
—
—
0.98
7.82
7.81
7.44
Cash per share
—
—
—
9.05
16.41
17.16
15.96
Net current asset value per share
—
—
—
10.82
18.6
19.8
18.96
Tangible book value per share
—
—
—
7.54
7.22
7.57
7.44
Working capital per share
—
—
—
7.97
14.36
14.9
14.43
Book value per share
—
—
—
7.54
7.22
7.57
7.44
Immunocore Holdings plc - American Depositary Shares
Immunocore is a global commercial-stage biotechnology company, based in Oxfordshire, which researches and develops biological drugs using soluble T-cell receptor technology.
News
FDA Grants Priority Review to SNY's Filing for Gaucher Disease Drug
TGTX's Single-Dose Briumvi Hits Bioequivalence Goal in MS Study
CORT to Resubmit NDA for Relacorilant in Cushing's Syndrome, Stock Up
AbbVie Wins FDA Nod for Decnupaz for Rare Blood Cancer Indication
Dyne Therapeutics Stock Gains 4.5% After BLA Filing for DMD Therapy
FDA Extends Review Time for AZN's Camizestrant Combo in Breast Cancer
Is it a Good Idea to Invest in Amneal Pharmaceuticals Stock Now?
AZN, Daiichi's Enhertu Gets Positive CHMP Opinion for Solid Tumors
AZN, Daiichi's Datroway Wins FDA Nod for Expanded Use in Breast Cancer
AGIO's Pyrukynd Gets Approval for Thalassemia in Europe
GILD Scores FDA Win for HDV Drug, CHMP Backs Trodelvy
CHMP Backs EU Approval of Novo Nordisk's Wegovy Pill for Obesity